Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-03EMA Authorised: Nexium Control (esomeprazole) — Haleon Ireland Dungarvan Limited
Authorised medicinal product Nexium Control (esomeprazole) by Haleon Ireland Dungarvan Limited for gastroesophageal reflux disease.
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
-
FDA approval · 2026-03-11FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) by Wal-Mart Stores Inc, enabling the store-brand generic prot…
-
EMA approval · 2026-03-02EMA Authorised: Nexium Control (esomeprazole) — Haleon Ireland Dungarvan Limited
The EMA authorized Nexium Control, a product containing esomeprazole, for gastroesophageal reflux disease, with Haleon Ireland Dungarvan Lim…
-
FDA approval · 2026-02-12FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength, a famotidine-containing product from Kenvue Brands LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
FDA approval · 2025-11-25FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole with sodium bicarbonate) submitted by Riley Consumer Care LLC.
-
FDA approval · 2025-11-12FDA Approved: DEXLANSOPRAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic version of Dexlansoprazole via an Original Application (ANDA 219115). The approval ad…
-
FDA approval · 2025-10-15FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Pantoprazole sodium, a generic pantoprazole product.
-
FDA approval · 2025-10-03FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
FDA approval · 2025-09-30FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete (famotidine with calcium carbonate and magnesium hydroxide) chewable tablets to …
-
FDA approval · 2025-08-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application to market generic lansoprazole.
-
FDA approval · 2025-08-01FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited, indicating an approved change to the ANDA.
-
FDA approval · 2025-07-16FDA Approved: FAMOTIDINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for famotidine from Sagent Pharmaceuticals, marking the approval of a generic product.
-
FDA approval · 2025-07-09FDA Approved: FAMOTIDINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original abbreviated new drug application (ANDA) for famotidine from Aurobindo Pharma Limited, a generic version of famotid…
-
FDA approval · 2025-06-02FDA Approved: FAMOTIDINE — Original Application (Lannett Company, Inc.)
FDA approved the original ANDA for famotidine from Lannett Company, Inc., establishing a generic version of famotidine.
-
FDA approval · 2025-05-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Devatis Inc.)
FDA approves Pantoprazole Sodium as an Original Application generic product from Devatis Inc. under ANDA 215074.
-
FDA approval · 2025-05-07FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for pantoprazole sodium intravenous formulation from Sandoz Inc., expanding the product to include I…
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, enabling its marketing as a generic drug in …
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for Esomeprazole Magnesium from Aurobindo Pharma Limited, adding a generic esomeprazole magnesium produ…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for aci…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for pantoprazole sodium injection, adding a new generic injectable panto…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pantoprazole Sodium from Aurobindo Pharma Limited, making a generic pantoprazole available. The pr…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's esomeprazole magnesium for delayed-release oral suspension via an original ANDA, confirming b…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals' esomeprazole magnesium delayed-release oral suspension via an original application, providing a generi…